Search

Your search keyword '"Rouger C"' showing total 101 results

Search Constraints

Start Over You searched for: Author "Rouger C" Remove constraint Author: "Rouger C"
101 results on '"Rouger C"'

Search Results

1. Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients – “En route for eradication”?

3. No relationship between late HIV diagnosis and social deprivation in newly diagnosed patients in France

4. Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus‐co‐infected patients (ANRS CO13‐HEPAVIH)

5. Efficacy and safety of dolutegravir and rilpivirine dual therapy as a simplification strategy: a cohort study

6. Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress?

7. Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?

8. Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients

9. Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma

10. Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen

11. Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma

14. Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients – “En route for eradication”?

23. Contribution de la PCR au diagnostic d'encéphalopathie toxoplasmique chez le sujet infecté par le virus de l'immuno-déficience humaine (VIH)

31. Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma

45. Human Immunodeficiency Virus Type 1 Group O Infection in France: Clinical Features and Immunovirological Response to Antiretrovirals

46. No relationship between late HIV diagnosis and social deprivation in newly diagnosed patients in France

48. Targeting of Antifungal Metabolites from Grapevine Byproducts by UPLC-HRMS/MS Approaches Using Bioactivity-Based Molecular Networking.

49. Valorization of Invasive Plant Extracts against the Bispecies Biofilm Staphylococcus aureus - Candida albicans by a Bioguided Molecular Networking Screening.

50. Naturally occurring phenolic compounds as promising antimycotoxin agents: Where are we now?

Catalog

Books, media, physical & digital resources